Faes Farma > Investors & shareholders > General information > Information sent to the CNMV > Other Relevant Information

Other Relevant Information

2023

Statement 11/30/2023. Interim dividend 2023.
Statement 10/25/2023. January- September 2023 results.
Statement 06/27/2023. News about bilastine.
Statement 05/04/2023. Acquisition Novosci.
Statement 04/26/2023. January-March 2023 results.
Statement 03/29/2023. Capital Markets Day presentation.
Statement 03/27/2023. Approval of the scrip dividend.
Statement 02/28/2023. Business update information 2022.

2022

Statement 12/22/2022. Appointments of Commissions.
Statement 10/27/2022. January- September 2022 results.
Statement 07/28/2022. January-June 2022 results.
Statement 04/29/2022. January-March 2022 results.
Statement 03/22/2022. Capital Market presentation.
Statement 02/25/2022. January-December results.

2021

Statement 10/29/2021. Financial results and business update third quarter 2021.
Statement 04/12/2021. Capital market presentation.
Statement 02/26/2021. Business update information 2020.
Statement 01/15/2021. Faes Farma expands its industrial capacity.

2020

Statement 10/29/2020. January-September results.
error: